Equifax Inc. (EFX) Reaches $143.07 High on Jun, 19; Natus Medical (BABY)’s Sentiment Is 1.93

June 19, 2017 - By Marie Mckinney

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has market cap of $1.17 billion. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It has a 32.23 P/E ratio.

The stock of Equifax Inc. (NYSE:EFX) reached all time high today, Jun, 19 and still has $153.08 target or 7.00% above today’s $143.07 share price. This indicates more upside for the $17.32B company. This technical setup was reported by Barchart.com. If the $153.08 PT is reached, the company will be worth $1.21B more. About 62,806 shares traded. Equifax Inc. (NYSE:EFX) has risen 11.28% since June 19, 2016 and is uptrending. It has underperformed by 5.42% the S&P500.

Ratings analysis reveals 100% of Natus Medical’s analysts are positive. Out of 2 Wall Street analysts rating Natus Medical, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. BABY was included in 2 notes of analysts from September 13, 2016. The rating was initiated by Benchmark on Tuesday, October 4 with “Buy”. The stock of Natus Medical Inc (NASDAQ:BABY) has “Outperform” rating given on Tuesday, September 13 by Raymond James.

Lyon Street Capital Llc holds 8.11% of its portfolio in Natus Medical Inc for 456,016 shares. Motley Fool Asset Management Llc owns 375,741 shares or 2.9% of their US portfolio. Moreover, Beddow Capital Management Inc has 2.57% invested in the company for 185,390 shares. The Delaware-based Ashford Capital Management Inc has invested 1.94% in the stock. Sio Capital Management Llc, a New York-based fund reported 90,865 shares.

About 14,426 shares traded. Natus Medical Inc (BABY) has risen 4.38% since June 19, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Since January 1, 0001, it had 2 insider buys, and 3 sales for $190,940 activity.

Analysts await Natus Medical Inc (NASDAQ:BABY) to report earnings on July, 19. They expect $0.33 EPS, down 15.38% or $0.06 from last year’s $0.39 per share. BABY’s profit will be $11.03M for 26.52 P/E if the $0.33 EPS becomes a reality. After $0.30 actual EPS reported by Natus Medical Inc for the previous quarter, Wall Street now forecasts 10.00% EPS growth.

Analysts await Equifax Inc. (NYSE:EFX) to report earnings on July, 26. They expect $1.57 earnings per share, up 9.79% or $0.14 from last year’s $1.43 per share. EFX’s profit will be $190.06 million for 22.78 P/E if the $1.57 EPS becomes a reality. After $1.44 actual earnings per share reported by Equifax Inc. for the previous quarter, Wall Street now forecasts 9.03% EPS growth.

Equifax Inc. is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The company has market cap of $17.32 billion. The Firm operates in four divisions: U.S. It has a 32.16 P/E ratio. Information Solutions , International, Workforce Solutions and Global Consumer Solutions.

Since February 15, 2017, it had 0 insider buys, and 10 sales for $18.17 million activity. Smith Richard F sold $9.74 million worth of stock. The insider Adams J Dann sold $1.08 million. Another trade for 14,000 shares valued at $1.91 million was made by GAMBLE JOHN W JR on Tuesday, May 23. 7,954 shares were sold by KING NUALA M, worth $1.03 million. $936,782 worth of stock was sold by Webb David on Tuesday, February 28. $340,139 worth of Equifax Inc. (NYSE:EFX) was sold by Hartman John T. on Tuesday, February 28. Loughran Joseph Michael III had sold 3,000 shares worth $390,484 on Tuesday, February 21.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: